Checklist to gauge real-world studies

Researchers have developed and tested a checklist that aims to evaluate comparative effectiveness research and distinguish real-world studies that are good enough for decision-making about treatments.

An agreed-upon set of assessment elements is important, say co-developers Quintiles and the National Pharmaceutical Council. Called the Good ReseArch for Comparative Effectiveness (GRACE) checklist, it features 11 items about research and data methods, based on existing literature and guidance from experts, and was published in the March issue of Journal of Managed Care Pharmacy.

GRACE stands out, said Quintiles Global Chief of Scientific Affairs and SVP Nancy Dreyer, lead author of the study, because it's been tested by “collaborators from public and private sectors in North and South America, Europe, Asia and Africa.”

You must be a registered member of MMM to post a comment.

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.